FI66370C - Foerfarande foer framstaellning av nya farmakologiskt anvaendbara piperidinopropylderivat - Google Patents
Foerfarande foer framstaellning av nya farmakologiskt anvaendbara piperidinopropylderivat Download PDFInfo
- Publication number
- FI66370C FI66370C FI800407A FI800407A FI66370C FI 66370 C FI66370 C FI 66370C FI 800407 A FI800407 A FI 800407A FI 800407 A FI800407 A FI 800407A FI 66370 C FI66370 C FI 66370C
- Authority
- FI
- Finland
- Prior art keywords
- group
- hydroxy
- propoxy
- piperidino
- general formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
- C07C205/56—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups bound to carbon atoms of six-membered aromatic rings and carboxyl groups bound to acyclic carbon atoms of the carbon skeleton
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Claims (3)
1. Förfarande för framställning av farmakologiskt användbara piperiäinopropylderivat med den allmänna formeln I ?3 /-v O-CH -CH-CH -N y CHo-0-B Λ-a (i> r, H- i 1 1 yJ— V. R2 R4 i vilken formel och R2, vilka kan vara lika eller olika, betecknar en väte-· atom eller en -Cg-alkylgrupp eller bildar tillsammans en C2-C4-alkylenrest, betecknar väte eller en grupp -O-Rg, väri betecknar väte eller en acetyl-, pivaloyl- eller bensoylrest, betecknar väte eller en formylrest, A betecknar en grupp , varvid X1 och Y1 kan vara lika eller olika och betecknar var för sig en kväveatom eller en grupp -C=, K väri Rg betecknar väte, en C.j-Cg-alkylgrupp, som eventuellt är substituerad med en grupp -O-R,., en karboxyl- eller C1-C/r-alkoxikarbonylgrupp, en grupp X2~Y2/ väri X2 betecknar en ^CH2~grupp eller en grupp ^N-R^, väri R^ är väte eller en C.j-Cg-alkylgrupp, och Y2 en 7ACH2~grupp eller en grupp ^;C=Z, varvid Z betecknar en syre-eller svavelatom, eller en grupp -CRg=CRg-, väri Rg och Rg tillsammans betecknar en -CH=CH-CH=CH-brygga, med det villkoret, att Y^ resp. Y2 är bundna vid resten 3^N-R4 i den allmänna formeln I, och B betecknar en pyridyl-, pyrimidyl-, bensimidazolinonyl-, bens-imidazolinyl-, benstriazolyl-, indazolyl-, bensodioxolanyl-eller karbazolylrest eller, för det fall A betecknar X2“Y2 eller -CRg=CRg-, även en fenylrest, som eventuellt är substituerad med en eller flera halogen-, hydroxi- eller C^-Cg-alkylgrupper, som eventuellt har en hydroxi- eller karboxamido- substituent, eller e,-C^-alkoxi-, amino-, karboxamido-, C..-C,- I o Ib alkylkarbonyland.no-, acetyl- eller -Cg-alkylsulfonylamino- grupper, och deras farmakologiskt acceptabla salter, 40 66370 kännetecknat av att man a) omsätter en förening med den allmänna formeln II o-ch2-u-ch2-v "· -fe-K. R2 med en förening med den allmänna formeln III H-l/ y~CH2-Q-B (III) i vilka formler R1, R2, R4, A och B har den ovan angivna be-tydelsen, V betecknar en reaktiv rest och U en grupp ^=C=0, ^CH-R^ eller ^CH-O-E, varvid R^ har den ovan angivna bety-delsen och E bildar tillsammans med V en enkel-bindning, och för det fall U betecknar en grupp ^TC=0, därpä reducerar, eller b) omsätter en förening med den allmänna formeln IV OH R2 R4 med en förening med den allmänna formeln V v-ch2-u-ch2-i/ \- ch2-o-b (V) i vilka formler R^, R2, R^, A, B, U och V har den ovan angivna betydelsen, och för det fall U betecknar en grupp ^.0=0, därpä reducerar, eller c) omsätter en förening med den allmänna formeln VI 66370 41 RT • 3 /—\ O-CH -CH-CH_-N V- CH„—O—B , 2 v.y 2
1 XH m> NH R„ I R4 i vilken formel , R^, R^ , R^ och B har den ovan angivna be-tydelsen och X betecknar HX1 eller X^, varvid, för det fall att A betecknar en -X^=Y^-grupp, en förening med den allmänna formeln VI, i vilken X betecknar gruppen HX^, omsättes med en förening med den allmänna formeln Vila L1 ^ L2 -Y1 (Vila) L3 i vilken formel Y^ har den ovan angivna betydelsen, betecknar en väteatom, en hydroxigrupp eller en reaktiv rest T, L2 betecknar en väteatom eller en reaktiv rest T, och L·^ betecknar en väteatom eller bildar tillsammans med gruppen L2 en syreatom, eller varvid, för det fall att A betecknar en X2-Y2~grupp, en förening med den allmänna formeln VI, i vilken formel X betecknar gruppen X2, omsättes med en förening med den allmänna formeln Vllb L1 ^ Y2 (Vllb) L2*^ i vilken formel och Y2 har den ovan angivna betydelsen, och L2' betecknar en väteatom eller en reaktiv rest T, och cyklise-rar, eller d) reducerar och cykliserar en förening med den allmänna formeln VIII
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19792905876 DE2905876A1 (de) | 1979-02-16 | 1979-02-16 | Neue piperidinopropylderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
DE2905876 | 1979-02-16 |
Publications (3)
Publication Number | Publication Date |
---|---|
FI800407A FI800407A (fi) | 1980-08-17 |
FI66370B FI66370B (fi) | 1984-06-29 |
FI66370C true FI66370C (fi) | 1984-10-10 |
Family
ID=6063043
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI800407A FI66370C (fi) | 1979-02-16 | 1980-02-11 | Foerfarande foer framstaellning av nya farmakologiskt anvaendbara piperidinopropylderivat |
Country Status (16)
Country | Link |
---|---|
US (1) | US4288442A (sv) |
EP (1) | EP0014928B1 (sv) |
JP (1) | JPS55113777A (sv) |
AT (1) | ATE968T1 (sv) |
AU (1) | AU529849B2 (sv) |
CA (1) | CA1115703A (sv) |
CS (2) | CS226008B2 (sv) |
DD (1) | DD149069A5 (sv) |
DE (2) | DE2905876A1 (sv) |
DK (1) | DK65780A (sv) |
ES (1) | ES8102719A1 (sv) |
FI (1) | FI66370C (sv) |
HU (1) | HU184238B (sv) |
IL (1) | IL59351A (sv) |
SU (2) | SU1021342A3 (sv) |
ZA (1) | ZA80787B (sv) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2901336A1 (de) | 1979-01-15 | 1980-07-24 | Boehringer Mannheim Gmbh | Neue arylether, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel |
SE8003278L (sv) | 1979-05-04 | 1980-11-05 | Continental Pharma | Fenyletylaminderivat |
DE3200304A1 (de) * | 1981-01-16 | 1982-08-26 | Sandoz-Patent-GmbH, 7850 Lörrach | 3-aminopropoxyaryl-derivate, ihre herstellung und sie enthaltende arzneimittel |
DE3209271A1 (de) * | 1982-03-13 | 1983-09-15 | Boehringer Mannheim Gmbh, 6800 Mannheim | Bicyclische phenolether, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel |
ZA848275B (en) * | 1983-12-28 | 1985-08-28 | Degussa | New piridine-2-ethers or pyridine-2-thioethers having a nitrogen-containing cycloaliphatic ring |
US5231184A (en) * | 1987-11-23 | 1993-07-27 | Janssen Pharmaceutica N.V. | Pridazinamine derivatives |
DE3839743A1 (de) * | 1988-11-25 | 1990-05-31 | Hoechst Ag | Verfahren zur herstellung von benzimidazolonen |
US5082847A (en) * | 1990-07-18 | 1992-01-21 | Syntex (U.S.A.) Inc. | Carbostyril compounds connected via an oxyalkyl group with a piperidine ring and having pharmaceutical utility |
US5741789A (en) | 1995-01-17 | 1998-04-21 | Eli Lilly And Company | Compounds having effects on serotonin-related systems |
US5576321A (en) * | 1995-01-17 | 1996-11-19 | Eli Lilly And Company | Compounds having effects on serotonin-related systems |
US5627196A (en) * | 1995-01-17 | 1997-05-06 | Eli Lilly And Company | Compounds having effects on serotonin-related systems |
US5789402A (en) * | 1995-01-17 | 1998-08-04 | Eli Lilly Company | Compounds having effects on serotonin-related systems |
US5614523A (en) * | 1995-01-17 | 1997-03-25 | Eli Lilly And Company | Compounds having effects on serotonin-related systems |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE255000C (sv) * | ||||
DE2550001A1 (de) | 1975-11-07 | 1977-05-12 | Boehringer Mannheim Gmbh | Neue indol-derivate und verfahren zu ihrer herstellung |
DE2701794A1 (de) * | 1976-01-21 | 1977-07-28 | Ciba Geigy Ag | Oxigenierte n-aryl-diazacyclen |
US4110333A (en) * | 1976-05-17 | 1978-08-29 | Janssen Pharmaceutica N.V. | 1,3-Dihydro-1-[3-(1-piperidinyl)propyl]-2H-benzimidazol-2-ones and related compounds |
US4146630A (en) * | 1976-11-12 | 1979-03-27 | Boehringer Mannheim Gmbh | Blood pressure lowering and adrenergic β-receptor inhibiting 3-(4-phenoxymethylpiperidino)-propyl-phenyl ethers |
DE2737630A1 (de) * | 1977-08-20 | 1979-03-01 | Boehringer Mannheim Gmbh | Neue aminopropanolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
US4200641A (en) * | 1976-12-21 | 1980-04-29 | Janssen Pharmaceutica, N.V. | 1-[(Heterocyclyl)-alkyl]-4-diarylmethoxy piperidine derivatives |
-
1979
- 1979-02-16 DE DE19792905876 patent/DE2905876A1/de not_active Withdrawn
-
1980
- 1980-01-29 CA CA344,561A patent/CA1115703A/en not_active Expired
- 1980-01-31 US US06/117,172 patent/US4288442A/en not_active Expired - Lifetime
- 1980-02-08 ES ES488401A patent/ES8102719A1/es not_active Expired
- 1980-02-10 IL IL59351A patent/IL59351A/xx unknown
- 1980-02-11 FI FI800407A patent/FI66370C/fi not_active IP Right Cessation
- 1980-02-11 EP EP80100670A patent/EP0014928B1/de not_active Expired
- 1980-02-11 AU AU55409/80A patent/AU529849B2/en not_active Ceased
- 1980-02-11 SU SU802879302A patent/SU1021342A3/ru active
- 1980-02-11 AT AT80100670T patent/ATE968T1/de active
- 1980-02-11 DE DE8080100670T patent/DE3060353D1/de not_active Expired
- 1980-02-12 ZA ZA00800787A patent/ZA80787B/xx unknown
- 1980-02-13 DD DD80219038A patent/DD149069A5/de unknown
- 1980-02-15 CS CS801056A patent/CS226008B2/cs unknown
- 1980-02-15 JP JP1671080A patent/JPS55113777A/ja active Pending
- 1980-02-15 CS CS807704A patent/CS226021B2/cs unknown
- 1980-02-15 HU HU80351A patent/HU184238B/hu unknown
- 1980-02-15 DK DK65780A patent/DK65780A/da not_active Application Discontinuation
-
1981
- 1981-02-05 SU SU813241895A patent/SU1241987A3/ru active
Also Published As
Publication number | Publication date |
---|---|
ZA80787B (en) | 1981-03-25 |
CS226008B2 (en) | 1984-03-19 |
CS226021B2 (en) | 1984-03-19 |
AU5540980A (en) | 1980-08-21 |
SU1021342A3 (ru) | 1983-05-30 |
DE3060353D1 (en) | 1982-06-24 |
EP0014928A1 (de) | 1980-09-03 |
ES488401A0 (es) | 1981-02-16 |
FI800407A (fi) | 1980-08-17 |
IL59351A0 (en) | 1980-05-30 |
IL59351A (en) | 1984-01-31 |
FI66370B (fi) | 1984-06-29 |
HU184238B (en) | 1984-07-30 |
EP0014928B1 (de) | 1982-05-05 |
AU529849B2 (en) | 1983-06-23 |
CA1115703A (en) | 1982-01-05 |
ES8102719A1 (es) | 1981-02-16 |
DK65780A (da) | 1980-08-17 |
US4288442A (en) | 1981-09-08 |
JPS55113777A (en) | 1980-09-02 |
DD149069A5 (de) | 1981-06-24 |
DE2905876A1 (de) | 1980-08-28 |
ATE968T1 (de) | 1982-05-15 |
SU1241987A3 (ru) | 1986-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI66370C (fi) | Foerfarande foer framstaellning av nya farmakologiskt anvaendbara piperidinopropylderivat | |
US6130235A (en) | Compounds and methods to treat cardiac failure and other disorders | |
US4346093A (en) | Heterocyclic oxypropanolamine compounds and pharmaceutical compositions | |
US20030073699A1 (en) | Compounds and methods to treat cardiac failure and other disorders | |
AU2004203356A1 (en) | Indole-type derivatives as inhibitors of p38 kinase | |
EA002778B1 (ru) | СЕЛЕКТИВНЫЕ β-АДРЕНЕРГИЧЕСКИЕ АГОНИСТЫ | |
WO1999061426A1 (en) | Heterocyclic compounds and methods to treat cardiac failure and other disorders | |
WO2002042292A2 (en) | Indol derivative and their use as inhibitors of p38 kinase | |
PL196774B1 (pl) | Pochodne indolilopiperydyny jako środki przeciwhistaminowe i przeciwalergiczne | |
FI62077C (fi) | Foerfarande foer framstaellning av farmaceutiskt anvaendbara fenoximetylpiperidinopropanolderivat | |
JPH0567624B2 (sv) | ||
US5330986A (en) | Indole-7-carboxamide derivatives | |
US6340685B1 (en) | Compounds and methods to treat cardiac failure and other disorders | |
US20040053956A1 (en) | Isoquinoline derivatives useful in the treatment of cns disorders | |
US4363808A (en) | N-(3-Phenoxy-2-hydroxypropyl)benzimidazole-1-alkanamines | |
US4337250A (en) | Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents | |
PL112154B1 (en) | Method of preparation of novel aminopropanol derivatives | |
US20070232619A1 (en) | Piperazine Derivatives of Dialkyl Oxindoles | |
US4432978A (en) | Hexahydro-trans-pyridoindole | |
US4438116A (en) | Quinoxalinyloxy-amino-propanol compounds with blood pressure lowering and β-blocking properties, their use and pharmaceutical compositions containing them | |
JPS6345667B2 (sv) | ||
US4434174A (en) | Treating cardiovascular diseases with N-(3-phenoxy-2-hydroxypropyl)benzimidazole-1-alkanamines | |
FR2605008A1 (fr) | Derives d'imidazo (4,5-b)pyridinone-2, leur preparation et leur application en therapeutique | |
US4431649A (en) | Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents | |
US4427679A (en) | Hexahydro-trans- and tetrahydropyridoindole neuroleptic agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM | Patent lapsed |
Owner name: BOEHRINGER MANNHEIM GMBH |